Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Recommendation of “Hold” from Analysts
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six ratings firms that are currently covering...
DraftKings’ (DKNG) “Buy” Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of DraftKings (NASDAQ:DKNG – Free Report) in a research report sent to investors on Wednesday,...
Oracle (NYSE:ORCL) PT Raised to $135.00 at Stifel Nicolaus
Oracle (NYSE:ORCL – Free Report) had its target price increased by Stifel Nicolaus from $120.00 to $135.00 in a research report released on Wednesday, Benzinga...
UBS Group Trims Huntington Bancshares (NASDAQ:HBAN) Target Price to $15.00
Huntington Bancshares (NASDAQ:HBAN – Free Report) had its price objective reduced by UBS Group from $16.00 to $15.00 in a research note published on Thursday,...
Innate Pharma (NASDAQ:IPHA) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Innate Pharma (NASDAQ:IPHA – Free Report) in a research report sent to investors on Wednesday morning,...
PAR Technology (NYSE:PAR) Raised to “Overweight” at Stephens
Stephens upgraded shares of PAR Technology (NYSE:PAR – Free Report) from an equal weight rating to an overweight rating in a report issued on Thursday,...